Understanding and Managing Drug Interactions in HIV Disease

12/12/01


Click here to start


Table of Contents

Understanding and Managing Drug Interactions in HIV Disease

Content

Basic Pharmacokinetic Parameters

Antiretroviral Pharmacodynamics

Potential Consequences of Antiretroviral Interactions

Hospitalizations Due to ADRs and Drug Interactions

Clinical Toxicity Associated with Increased Drug Exposure

Nephrotoxicity and IDV concentrations

Dose-Response Effect of Protease Inhibitors?

TRILEGE: Indinavir Levels in Naïve Patients Taking AZT/3TC/Indinavir

VIRADAPT: Efficacy According to Drug Levels & Randomization Arm

Principles of Drug Interactions

Sites in the Body for Drug Interactions

Absorption Interactions

Antiretroviral-Food Interactions

Gastric pH Interactions

Chelation Interactions

Summary of Antiretroviral Absorption Interactions

P-Glycoprotein

Mechanism of PGP transport

P-Glycoprotein Interactions

P-Glycoprotein and Protease Inhibitors

Increases in Protease CSF concentrations with Ketoconazole (P-gp inhibitor)

Routes of Drug Metabolism

Metabolic Interactions

Cytochrome P450 Enzymes

Substrate

Enzyme Inhibitor

Selectivity - Which CYP Isozymes?

Potency

Enzyme Inhibition Interactions

Enzyme Inducer

Enzyme Induction Interactions

Some Antiretrovirals May Induce and Inhibit CYP450

Effect on CYP450 - Summary

Pharmacokinetically Enhanced Protease Inhibitor Combinations

Dual Protease Combinations

Double Protease Combinations (2)

Steady State Indinavir Plasma Profile after Indinavir + Ritonavir 400 mg q12h with Food

Ritonavir Boosted PI Regimens

Ritonavir Enhances Kinetics of Other Protease Inhibitors

Impact of Ritonavir on Protease Concentrations

Effect of Drug Dose on the Pharmacokinetics of Dual Protease Inhibitor Regimens

Advantages of Ritonavir-Boosted Regimens

Boosting Protease Levels May Expand Antiviral Activity

Indinavir 800 mg with Ritonavir 200 mg q12h

Saquinavir Intensification

Disadvantages of Ritonavir Boosted Regimens

Boosted PI Regimens Plus NNRTIs

Effect of Delavirdine on Protease Inhibitor Concentrations

Delavirdine Boosted Regimens (2)

Boosted Regimens - Summary

Undesirable Antiretroviral Interactions

PI-NNRTI Combinations: Effect on PI AUC

Antiretrovirals + MAC/TB Agents

Anticonvulsant Interactions: PI-Carbamazepine (CBZ)

St. John’s Wort + Indinavir

Drugs to Avoid/Use with Caution with Protease Inhibitors

Systematic Approach to Managing Drug Interactions

Systematic Approach to Managing Drug Interactions (2)

Evaluate Therapeutic Alternatives

Summary

Case Study Review

Case #1 - Ms. MC

Potential Interactions

Case #2 - Mr. JS

Potential Methadone Interaction?

Case #3 - Mr. GM

Three Weeks Later...

Case #4: Problem Solving

What If… Patient Wants to Take Zyban (bupropion)?

What If… Patient Requires a Sedative?

What If… Patient Requires MAC Prophylaxis?

What If…Patient Wants to Use Viagra?

Summary

Bibliography

Author: dr. Alice Tseng

Email: Alice.Tseng@uhn.on.ca

Home Page: www.tthhivclinic.com

 

Production & publication of this slide kit was made possible through an unrestricted educational grant from Agouron Pharmaceuticals Canada Inc.